CHD4 and coronary artery disorder: These lists include (1) a set of non-cilia genes previously implicated in CHD4,5,14–16 (referred to as the CHD list), (2) a set of chromatin-modifying genes found to be disrupted in CHD patients3–5 and (3) several gene lists assembled from the reactome17 and other pathway databases representing candidate genes and pathways associated with CHD including Notch, TGF-β, non-cilia cytoskeletal, and receptor serine–threonine kinase genes.